This article reviews the effect of biotherapy in ra including tumor necrosis factor inhibitor, IL-1inhibitor, stem cell transplantation genetic therapy and so on.
本文综述了包括肿瘤坏死因子抑制剂、白细胞介素1抑制剂、干细胞移植及基因治疗等生物治疗在类风湿性关节炎治疗中的作用。
Objective To investigate the circadian variation of serum interleukin 6 (IL 6) and cortisol and their clinical value in rheumatoid arthritis (RA) patients.
目的研究类风湿关节炎（RA）患者血清白细胞介素（IL）6、皮质醇节律及其临床意义。
In recent years studies, it has been shown that IL-18 participated in the genesis of RA, which has become a new hot spot of RA study.
近年发现，白细胞介素- 18可作用于RA发病的多个参与因素，成为研究RA的新热点。
In patients with morning symptoms of RA, there may be insufficient endogenous cortisol released during the night to counter elevated levels of the pro-inflammatory cytokine, interleukin (IL) -6.
早晨有关节症状的RA患者，可能是由于夜间内源性皮质醇释放不足导致促炎性细胞因子(如il - 6)水平升高。
In patients with morning symptoms of RA, there may be insufficient endogenous cortisol released during the night to counter elevated levels of the pro-inflammatory cytokine, interleukin (IL) -6.
早晨有关节症状的RA患者，可能是由于夜间内源性皮质醇释放不足导致促炎性细胞因子(如il - 6)水平升高。
应用推荐